{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:23:47Z","timestamp":1792092227217,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.chroma.2024.465559","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T16:52:34Z","timestamp":1732899154000},"page":"465559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Enhancing the practicality along with greenness sustainability of a high throughput HPLC-MS\/MS bioanalytical method for the simultaneous determination of amlodipine, perindopril, and its active metabolite perindoprilat in human plasma: Application to a pharmacokinetic study"],"prefix":"10.1016","volume":"1740","author":[{"given":"Ehab F.","family":"Elkady","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3981-1754","authenticated-orcid":false,"given":"Marwa A.","family":"Moffid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman A.","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawda M.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2024.465559_bib0001","unstructured":"T.A.P. Karen Whalen, Richard S. Finkel, Pharmacology lippincott's illustrated reviews, 6th ed., Wolters Kluwer Health, 2014."},{"key":"10.1016\/j.chroma.2024.465559_bib0002","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","article-title":"Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials","volume":"122","author":"Wald","year":"2009","journal-title":"Am. J. Med."},{"issue":"2007","key":"10.1016\/j.chroma.2024.465559_bib0003","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the european society of hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"25","author":"Mancia","year":"2007","journal-title":"J. Hypertens."},{"key":"10.1016\/j.chroma.2024.465559_bib0004","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/1755-5922.12015","article-title":"Hypertension management: rationale for triple therapy based on mechanisms of action","volume":"31","author":"Neutel","year":"2013","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.chroma.2024.465559_bib0005","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1751-7176.2010.00360.x","article-title":"Rationale for triple-combination therapy for management of high blood pressure","volume":"12","author":"Gradman","year":"2010","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"10.1016\/j.chroma.2024.465559_bib0006","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1161\/HYPERTENSIONAHA.109.132688","article-title":"Triple fixed-dose combination therapy: back to the past","volume":"54","author":"Black","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.chroma.2024.465559_bib0007","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/1753944709334947","article-title":"A role for single-pill triple therapy in hypertension","volume":"3","author":"Elijovich","year":"2009","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"10.1016\/j.chroma.2024.465559_bib0008","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cjca.2016.02.066","article-title":"Hypertension Canada's 2016 Canadian hypertension education program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension","volume":"32","author":"Leung","year":"2016","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.chroma.2024.465559_bib0009","series-title":"Martindale: The Complete Drug Reference","author":"Sweetman","year":"2020"},{"key":"10.1016\/j.chroma.2024.465559_bib0010","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.amjmed.2010.08.007","article-title":"Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema","volume":"124","author":"Makani","year":"2011","journal-title":"Am. J. Med."},{"key":"10.1016\/j.chroma.2024.465559_bib0011","first-page":"670","article-title":"Effects of nifedipine and indomethacin on cough induced by angiotensin-converting enzyme inhibitors: a double-blind, randomized, cross-over study","volume":"19","author":"Fogari","year":"1992","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.chroma.2024.465559_bib0012","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12325-018-0675-3","article-title":"Effectiveness of a fixed-dose, single-pill combination of perindopril and amlodipine in patients with hypertension: a non-interventional study","volume":"35","author":"Fleig","year":"2018","journal-title":"Adv. Ther."},{"key":"10.1016\/j.chroma.2024.465559_bib0013","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ihj.2020.08.007","article-title":"ACEI-induced cough: a review of current evidence and its practical implications for optimal CV risk reduction","volume":"72","author":"Pinto","year":"2020","journal-title":"Indian Heart J."},{"key":"10.1016\/j.chroma.2024.465559_bib0014","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2165\/11316710-000000000-00000","article-title":"Fixed-dose combinations as initial therapy for hypertension: a review of approved agents and a guide to patient selection","volume":"69","author":"Waeber","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.chroma.2024.465559_bib0015","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1080\/03007995.2018.1433648","article-title":"Modifications in drug adherence after switch to fixed-dose combination of perindopril\/amlodipine in clinical practice. Results of a large-scale Italian experience. The amlodipine-perindopril in real settings (AMPERES) study","volume":"34","author":"Degli Esposti","year":"2018","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.chroma.2024.465559_bib0016","first-page":"5","article-title":"A brief review on analytical techniques in bioequivalence studies, Jcpr.InSK Kosuru, T Suvarna, G Jyothi, KSS Saran","author":"Kumar Kosuru","year":"2024","journal-title":"PS Sundhar J. Clin. Pharmaceut. Res."},{"key":"10.1016\/j.chroma.2024.465559_bib0017","doi-asserted-by":"crossref","first-page":"S1409","DOI":"10.1016\/j.arabjc.2013.04.016","article-title":"Analytical techniques in pharmaceutical analysis: a review","volume":"10","author":"Siddiqui","year":"2017","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.chroma.2024.465559_bib0018","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1039\/C9AN02145K","article-title":"Current developments in LC-MS for pharmaceutical analysis","volume":"145","author":"Beccaria","year":"2020","journal-title":"Analyst"},{"key":"10.1016\/j.chroma.2024.465559_bib0019","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5958\/2231-5675.2020.00030.7","article-title":"An overview: lC-ms as tool of sample extraction and quantification in bioanalytical laboratories","volume":"10","author":"Pramod","year":"2020","journal-title":"Asian J. Pharmaceut. Analy."},{"key":"10.1016\/j.chroma.2024.465559_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115553","article-title":"Plackett\u2013Burman and face-centered composite designs for development and optimization of chromatographic method for the simultaneous determination of glycopyrronium, indacaterol and mometasone in their fixed dose combination inhaler\u2013Green profile assessment","volume":"234","author":"Youssef","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2024.465559_bib0021","first-page":"1","author":"P\u0142otka-Wasylka","year":"2019","journal-title":"History Milestones Green Analyt. Chem."},{"key":"10.1016\/j.chroma.2024.465559_bib0022","series-title":"Challenges in green analytical chemistry","author":"Garrigues","year":"2020"},{"key":"10.1016\/j.chroma.2024.465559_bib0023","article-title":"Comparative study of two versatile multi-analyte chromatographic methods for determination of diacerein together with four non-steroidal anti-inflammatory drugs: greenness appraisal using Analytical Eco-Scale and AGREE metrics","volume":"28","author":"El-Kafrawy","year":"2022","journal-title":"Sustain. Chem. Pharm."},{"key":"10.1016\/j.chroma.2024.465559_bib0024","doi-asserted-by":"crossref","first-page":"109511","DOI":"10.1016\/j.microc.2023.109511","article-title":"Development of a simple, eco-friendly HPLC-DAD method for tulathromycin analysis: ensuring stability and assessing greenness","volume":"195","author":"Algethami","year":"2023","journal-title":"Microchemical J."},{"key":"10.1016\/j.chroma.2024.465559_bib0025","doi-asserted-by":"crossref","first-page":"115923","DOI":"10.1016\/j.trac.2020.115923","article-title":"Strategies of molecular imprinting-based solid-phase extraction prior to chromatographic analysis","volume":"128","author":"Arabi","year":"2020","journal-title":"Trends Analyt. Chem."},{"key":"10.1016\/j.chroma.2024.465559_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2021.123046","article-title":"Green analytical chemistry metrics: a review","volume":"238","author":"Sajid","year":"2022","journal-title":"Talanta"},{"key":"10.1016\/j.chroma.2024.465559_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2021.116223","article-title":"White analytical chemistry: an approach to reconcile the principles of green analytical chemistry and functionality","volume":"138","author":"Nowak","year":"2021","journal-title":"Trends Analyt. Chem."},{"key":"10.1016\/j.chroma.2024.465559_bib0028","first-page":"61","article-title":"Spectrophotometric resolution methods for determination of dimenhydrinate and cinnarizine in presence of their toxic impurities: greenness, environmental","author":"Morgan","year":"2023","journal-title":"Bull. Fac. Pharmacy"},{"key":"10.1016\/j.chroma.2024.465559_bib0029","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1039\/D3GC02347H","article-title":"Blue applicability grade index (BAGI) and software: a new tool for the evaluation of method practicality","volume":"25","author":"Manousi","year":"2023","journal-title":"Green Chem."},{"key":"10.1016\/j.chroma.2024.465559_bib0030","first-page":"1","article-title":"Determination of amlodipine, indapamide and perindopril in human plasma by a novel LC-MS\/MS method: application to a bioequivalence study","volume":"35","author":"Rezk","year":"2021","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.chroma.2024.465559_bib0031","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jpha.2018.05.004","article-title":"Simultaneous determination of indapamide, perindopril and perindoprilat in human plasma or whole blood by UPLC-MS\/MS and its pharmacokinetic application","volume":"8","author":"Tao","year":"2018","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.chroma.2024.465559_bib0032","doi-asserted-by":"crossref","first-page":"122585","DOI":"10.1016\/j.jchromb.2021.122585","article-title":"Simultaneous determination of indapamide, perindopril and its active metabolite perindoprilat in human plasma using UPLC-MS\/MS method","volume":"1169","author":"a","year":"2021","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.chroma.2024.465559_bib0033","unstructured":"ICH Harmonised Guideline: Bioanalytical method validation and study sample analysis M10, (n.d.). https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-guideline-m10-bioanalytical-method-validation-step-5_en.pdf."}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967324009324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967324009324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T09:05:17Z","timestamp":1735463117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967324009324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":33,"alternative-id":["S0021967324009324"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2024.465559","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing the practicality along with greenness sustainability of a high throughput HPLC-MS\/MS bioanalytical method for the simultaneous determination of amlodipine, perindopril, and its active metabolite perindoprilat in human plasma: Application to a pharmacokinetic study","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2024.465559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"465559"}}